Evidence map›Paper›PMID 34300680›Full record

ArticleSensors (Basel, Switzerland)2021

Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring.

Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen, Ariel Dora Stern

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. [Researches and clinical translation of smart dressings].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Ethics of Wearable-Based Out-of-Hospital Cardiac Arrest Detection.Circulation. Arrhythmia and electrophysiology · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. [Digitalization of healthcare and its effects on quality of care].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jan Benedikt BrönnekeHealth Innovation Hub, Torstr. 223, 10785 Berlin, Germany.
Jennifer MüllerHelios Health Institute, Helios Health, Friedrichstraße 136, 10117 Berlin, Germany.
Konstantinos MouratisHerzzentrum Leipzig, Universitätsklinik für Kardiologie, Strümpellstraße 39, 04289 Leipzig, Germany.ORCID 0000-0002-5216-9719
Julia HagenHealth Innovation Hub, Torstr. 223, 10785 Berlin, Germany.
Ariel Dora SternHealth Innovation Hub, Torstr. 223, 10785 Berlin, Germany.ORCID 0000-0002-3586-1041
Deutsches Herzzentrum der Charité · DEHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern market access are often evolving slowly, sometimes creating market barriers. This article gives a brief overview of the existing clinical studies regarding the use of smart wearables in cardiac monitoring and provides insight into the main regulatory and legal aspects that need to be considered when such products are intended to be used in a health care setting. Based on this brief overview, the article elaborates on the specific requirements in the main areas of authorization/certification and reimbursement/compensation, as well as data protection and data security. Three case studies are presented as examples of specific market access procedures: the USA, Germany, and Belgium. This article concludes that, despite the differences in specific requirements, market access pathways in most countries are characterized by a number of similarities, which should be considered early on in product development. The article also elaborates on how regulatory and legal requirements are currently being adapted for digitally driven wearables and proposes an ongoing evolution of these requirements to facilitate market access for beneficial medical technology in the future.

Indexed as

Computer SecurityWearable Electronic DevicesBelgiumGermanyMonitoring, Physiologicmarket accessmedical devicesregulationsmart wearables

Identifiers

PMID34300680
PMCPMC8309890
OpenAlexW3183428606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.